
Elisa M. Rice
Examiner (ID: 18639, Phone: (571)270-1582 , Office: P/2669 )
| Most Active Art Unit | 2669 |
| Art Unit(s) | 2669, 2624 |
| Total Applications | 370 |
| Issued Applications | 269 |
| Pending Applications | 9 |
| Abandoned Applications | 94 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18647846
[patent_doc_number] => 20230293622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SAUVIGNON BLANC GRAPE SEED PRODUCTS FOR NONALCOHOLIC FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/063281
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063281 | SAUVIGNON BLANC GRAPE SEED PRODUCTS FOR NONALCOHOLIC FATTY LIVER DISEASE | Dec 7, 2022 | Pending |
Array
(
[id] => 18418434
[patent_doc_number] => 20230172892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 18/075980
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 103128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/075980 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Dec 5, 2022 | Issued |
Array
(
[id] => 18282880
[patent_doc_number] => 20230098352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD OF INCREASING BIOAVAILABILITY AND/OR PROLONGING OPHTHALMIC ACTION OF A DRUG
[patent_app_type] => utility
[patent_app_number] => 18/061848
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061848
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061848 | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | Dec 4, 2022 | Issued |
Array
(
[id] => 19722086
[patent_doc_number] => 20250024837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => PESTICIDE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/711564
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -106
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18711564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/711564 | PESTICIDE SYSTEM | Nov 20, 2022 | Pending |
Array
(
[id] => 18360595
[patent_doc_number] => 20230142186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Rucaparib particles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/053557
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053557 | Rucaparib particles and uses thereof | Nov 7, 2022 | Issued |
Array
(
[id] => 18550646
[patent_doc_number] => 20230248646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => CROMOLYN COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/972772
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972772 | CROMOLYN COMPOSITIONS AND METHODS THEREOF | Oct 24, 2022 | Pending |
Array
(
[id] => 18339236
[patent_doc_number] => 20230131185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => ANTI-VIRAL CLEANING COMPOSITION, METHOD OF MAKING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/045075
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045075 | Anti-viral cleaning composition, method of making and use thereof | Oct 6, 2022 | Issued |
Array
(
[id] => 20451780
[patent_doc_number] => 12514823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Bioerodible drug delivery devices
[patent_app_type] => utility
[patent_app_number] => 17/959746
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4611
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959746
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959746 | Bioerodible drug delivery devices | Oct 3, 2022 | Issued |
Array
(
[id] => 19629561
[patent_doc_number] => 20240408010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes
[patent_app_type] => utility
[patent_app_number] => 18/697581
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18697581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/697581 | A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes | Sep 29, 2022 | Pending |
Array
(
[id] => 19541801
[patent_doc_number] => 20240358837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Amorphous Photosensitizing Particles, Methods For The Preparation Thereof, And Methods For The Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/692813
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692813
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692813 | Amorphous Photosensitizing Particles, Methods For The Preparation Thereof, And Methods For The Use Thereof | Sep 15, 2022 | Pending |
Array
(
[id] => 18252095
[patent_doc_number] => 20230079134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => EXTENDED RELEASE, ABUSE DETERRENT DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 17/946243
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946243 | Extended release, abuse deterrent dosage forms | Sep 15, 2022 | Issued |
Array
(
[id] => 18255612
[patent_doc_number] => 20230082651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/945012
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945012 | STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME | Sep 13, 2022 | Pending |
Array
(
[id] => 19722666
[patent_doc_number] => 20250025417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => ORAL ABIRATERONE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/689500
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18689500
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/689500 | ORAL ABIRATERONE FORMULATIONS | Sep 6, 2022 | Pending |
Array
(
[id] => 19682212
[patent_doc_number] => 20250000757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT
[patent_app_type] => utility
[patent_app_number] => 18/690379
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690379 | AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT | Aug 31, 2022 | Pending |
Array
(
[id] => 18238223
[patent_doc_number] => 20230070534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Bis-Choline Tetrathiomolybdate for Treating Wilson Disease
[patent_app_type] => utility
[patent_app_number] => 17/821786
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821786 | Bis-choline tetrathiomolybdate for treating Wilson Disease | Aug 22, 2022 | Issued |
Array
(
[id] => 19996568
[patent_doc_number] => 20250134790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => ANTIMICROBIAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/681256
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681256 | ANTIMICROBIAL COMPOSITIONS | Aug 10, 2022 | Pending |
Array
(
[id] => 20356167
[patent_doc_number] => 12472146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Extended release pharmaceutical formulation
[patent_app_type] => utility
[patent_app_number] => 17/883902
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 25
[patent_no_of_words] => 17967
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1058
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17883902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/883902 | Extended release pharmaceutical formulation | Aug 8, 2022 | Issued |
Array
(
[id] => 19462274
[patent_doc_number] => 20240315943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => LIGHT-COLORED CATECHOL LIGNOSULFONATE SUNSCREEN MICROCAPSULE, AND PREPARATION THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/291029
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291029 | LIGHT-COLORED CATECHOL LIGNOSULFONATE SUNSCREEN MICROCAPSULE, AND PREPARATION THEREFOR AND USE THEREOF | Jul 27, 2022 | Pending |
Array
(
[id] => 17981068
[patent_doc_number] => 20220347104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/851590
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851590 | Extended release pharmaceutical formulation and methods of treatment | Jun 27, 2022 | Issued |
Array
(
[id] => 17988761
[patent_doc_number] => 20220354798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/851451
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851451 | Extended release pharmaceutical formulation and methods of treatment | Jun 27, 2022 | Issued |